Upregulation of MKP-1 by AAVMKP-1 reversed the impairment of LTP (194.68 ± 9.32% to baseline, p < 0.001), whereas AAVshMKP-1 treatment did not affect LTP in AD mice (Fig. 6g–i). Here, DUSP1 is linked to Alzheimer disease.